Commercial Sales Result in Addition of PQRS for Physician Groups Using QualOptima Technology to Position Quture as First-Mover in Clinical Outcomes Analytics for Maximum Penetration of Estimated $2.5 Billion Annual U.S. Healthcare Market
DAYTONA BEACH, FL / ACCESSWIRE / January 20, 2015 / Quture International, Inc. ("Q") (OTC Pink: QUTR) (PINKSHEETS: QUTR), the proven and experienced clinical performance and outcome analytics and solutions company in American healthcare, now with global capability, today announced the application of its QualOptima product for physicians and physician groups for the Medicare Physician Quality Reporting System (PQRS). Q has previously announced QualOptima innovations for hospitals, using the same precise metrics now required for filing PQRS by physicians. Adding the physician market segment of users will dramatically increase demand for the product and is parallel to the urgent needs in health care to electronically capture precise numerator and denominator metrics for performance and outcomes measurement for hospitals. The clinical outcomes analytics market was previously estimated at $2.5 billion in the United States healthcare market alone, which is rapidly expanding to the global market, and now dramatically increased by physicians and physician groups in the U.S.
In early sales and installations initiatives, Q is working with physician groups in medical specialties such as radiology, to use its natural language processing (NLP) and interface engine technologies to electronically capture performance and outcomes metrics to satisfy PQRS requirements. Several pilot demonstration installations are intended to result in announcements of luminary sites that license and use Q's technology for PQRS by physician groups. PQRS is required in 2015 by CMS "Physician Value Based Payment Modifier (VM) Changes" announced by Medicare for the 2015 Physician Fee Schedule Final Rule.
"Q's Go to Market Plan, as previously announced, is now dramatically demonstrated for the physician market segment in the United States," said Landon Feazell, Chairman and CEO of Quture. "Our confidence in Q's intellectual property and technology to become the market leader from our first mover position in clinical outcomes analytics and solutions continues to increase exponentially as the needs of healthcare customers evolve. In addition to physicians and physician groups, Q's Go to Market Plan envisions potential customer segments ranging from providers like hospitals, HMO's and Accountable Care Organizations, to payers like health insurers and exchanges and other insurers, especially medical malpractice companies, to pharmaceutical companies and medical device manufacturers, to consultants like healthcare law firms, financial and accounting firms, as well as regulators and government entities."
Q is in final stages of patent filings of its intellectual property by its patent attorney, which will immediately be followed by publication of its new website fully describing its products and services. The intention of Q is to have its SEC filings team, as previously announced, complete the Company’s demonstration of its position of strength in the global health and healthcare market. Q's commercial marketing and installations of these QualOptima versions have also required expanding Q management, staff and infrastructure. The Go to Market Plan focuses on the initial market of Q to healthcare providers and payers to achieve optimal clinical, financial and operational outcomes.
The QualOptima Analytics & Connectivity System is transformative technology to enhance clinical performance to achieve optimal patient outcomes. As the free enterprise solution to improving health and healthcare while reducing costs, Q is positioned through its disruptive technology to become the foremost global provider of value-based clinical intelligence and knowledge solutions.
"Our short-term strategy is to remain laser focused on installations at reference sites of Q's core technology as demonstrated in the formal Clinical Trial at the University of Miami and now using additional metrics from strategically selected medical specialties. We intend to rapidly grow our system of analytics into all medical specialties and across these traditional boundaries and silos of information. Our long-term strategy is to market and provide the platform and clinical knowledge solutions empowering interchange of information between patients, providers and payers for the changing medical model," said Feazell. "The power of our technology platform is intended to connect all constituents with health and healthcare information. Initiatives for population health management by enabled patients and for telecommunications using remote monitoring devices and mobile applications should incorporate and rely upon Q's core intellectual property. Our unique system of personalized risk factors and outcomes from optimal health and care models allows us to be confident in our marketing and technology development strategies for Q's short and long-term future."
About Quture International, Inc.
Quture International (OTCQB: QUTR) is the proven and experienced clinical performance and outcome analytics and solutions company in American healthcare. Q's first-to-market clinical intelligence software is the complete solution for healthcare providers, payers, employers, and insurance companies seeking to achieve optimal clinical, financial and operational outcomes. Q's QualOptima Connectivity & Analytics System empowers value-driven, patient-centered, personalized care focused on real-time and predictive patient management and patient safety, with optimal quality demonstrated by outcomes correlated with resource use, revenue and cost. Q's core competence and value proposition lies in its embedded evidence-based metrics, clinical content and analytic algorithms developed from over 35 years of measuring performance in hundreds of hospitals and HMOs, by thousands of physicians, clinicians and nurses, of hundreds of thousands of patients. As the free enterprise solution to improving health and healthcare while reducing costs, Q is positioned through its disruptive technology to become the foremost global provider of value-based clinical intelligence and knowledge solutions. Q is a Nevada corporation based in Daytona Beach, Florida, and trades on the OTC exchange under the symbol "QUTR".
Forward Looking Statements:
This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. There is no assurance that a definitive agreement will be completed.
CONTACT:
For Further Information Contact:
Infinity Advisors, Mark Kroeger
(239) 777-2977
[email protected]
SOURCE: Quture International, Inc.